These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25587694)

  • 41. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
    Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
    Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Symptomatic resolution among Chinese patients with schizophrenia and associated factors.
    Li CT; Su TP; Chou YH; Lee YC; Liu ME; Ku HL; Shan IK; Bai YM
    J Formos Med Assoc; 2010 May; 109(5):378-88. PubMed ID: 20497871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermittent versus continuous central administration of clozapine in DBA/2 mice, improvement in sensory inhibition deficits.
    Stevens KE; Zheng L; Abrams DJ
    Schizophr Res; 2013 Sep; 149(1-3):121-6. PubMed ID: 23863771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of treatment satisfaction of schizophrenia patients: results from the ESPASS study.
    Nordon C; Rouillon F; Barry C; Gasquet I; Falissard B
    Schizophr Res; 2012 Aug; 139(1-3):211-7. PubMed ID: 22704996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia.
    Mallinger JB; Fisher SG; Brown T; Lamberti JS
    Psychiatr Serv; 2006 Jan; 57(1):133-6. PubMed ID: 16399976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clozapine conflict.
    Carpenter WT; Conley RR; Buchanan RW; Breier A; Tamminga CA
    Am J Psychiatry; 1996 Nov; 153(11):1505-7. PubMed ID: 8890695
    [No Abstract]   [Full Text] [Related]  

  • 48. Schizophrenia diagnosis and anterior hippocampal volume make separate contributions to sensory gating.
    Thoma RJ; Hanlon FM; Petropoulos H; Miller GA; Moses SN; Smith A; Parks L; Lundy SL; Sanchez NM; Jones A; Huang M; Weisend MP; Cañive JM
    Psychophysiology; 2008 Nov; 45(6):926-35. PubMed ID: 18823427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensory Gating Capacity and Attentional Function in Adults With ADHD: A Preliminary Neurophysiological and Neuropsychological Study.
    Micoulaud-Franchi JA; Lopez R; Cermolacce M; Vaillant F; Péri P; Boyer L; Richieri R; Bioulac S; Sagaspe P; Philip P; Vion-Dury J; Lancon C
    J Atten Disord; 2019 Aug; 23(10):1199-1209. PubMed ID: 26896149
    [No Abstract]   [Full Text] [Related]  

  • 50. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.
    Hagger C; Buckley P; Kenny JT; Friedman L; Ubogy D; Meltzer HY
    Biol Psychiatry; 1993 Nov; 34(10):702-12. PubMed ID: 8292674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice.
    Aleksandrov AA; Dmitrieva ES; Volnova AB; Knyazeva VM; Gainetdinov RR; Polyakova NV
    Neuroreport; 2019 Oct; 30(15):1004-1007. PubMed ID: 31503202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurocognitive functioning and facial affect recognition in treatment-resistant schizophrenia treated with clozapine.
    Machado de Sousa JP; Hallak JE
    Schizophr Res; 2008 Dec; 106(2-3):371-2. PubMed ID: 18845421
    [No Abstract]   [Full Text] [Related]  

  • 53. On the correlation between perceptual inundation caused by realistic immersive environmental auditory scenes and the sensory gating inventory in schizophrenia.
    El-Kaim A; Aramaki M; Ystad S; Kronland-Martinet R; Cermolacce M; Naudin J; Vion-Dury J; Micoulaud-Franchi JA
    Eur Psychiatry; 2015 Jul; 30(5):606-14. PubMed ID: 25700728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of clozapine on the speed and accuracy of information processing in schizophrenia.
    Galletly CA; Clark CR; McFarlane AC; Weber DL
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1329-38. PubMed ID: 11125857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study.
    Ji B; Mei W; Zhang JX; Jing J; Wu Q; Zhuo Y; Xiao Z
    Exp Brain Res; 2013 Aug; 229(2):139-47. PubMed ID: 23820976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine.
    O'Connell KE; Thakore J; Dev KK
    Schizophr Res; 2014 Jun; 156(1):1-8. PubMed ID: 24742875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Capgras syndrome in a very late onset, treatment resistant schizophrenia.
    Ain MK; Rosdinom R; Raynuha M
    Int Psychogeriatr; 2015 Sep; 27(9):1573-5. PubMed ID: 25794136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A diagnostic model incorporating P50 sensory gating and neuropsychological tests for schizophrenia.
    Shan JC; Liu CM; Chiu MJ; Liu CC; Chien YL; Hwang TJ; Lin YT; Hsieh MH; Jaw FS; Hwu HG
    PLoS One; 2013; 8(2):e57197. PubMed ID: 23460831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition.
    d'Alfonso AA; Aleman A; Kessels RP; Schouten EA; Postma A; van Der Linden JA; Cahn W; Greene Y; de Haan EH; Kahn RS
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):77-9. PubMed ID: 11884659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia.
    Becker J; Gomes I; Ghisolfi ES; Schuch A; Ramos FL; Ehlers JA; Nora DB; Lara DR; da Costa JC
    Clin Neurophysiol; 2004 Feb; 115(2):396-401. PubMed ID: 14744582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.